Prelude Capital Management, LLC Denali Therapeutics Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $388 - $603	-26 Reduced 0.25%	10,343 $240,000
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $395 - $583	25 Added 0.24%	10,369 $212,000
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $648 - $927	40 Added 0.39%	10,344 $221,000
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $6,911 - $10,106	-335 Reduced 3.15%	10,304 $212,000
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $16,359 - $23,072	-700 Reduced 6.17%	10,639 $313,000
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $87,552 - $130,549	3,996 Added 54.42%	11,339 $261,000
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $192,974 - $249,074	7,343 New	7,343 $204,000
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $278,690 - $454,264	-9,610 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $153,238 - $197,961	3,598 Added 59.85%	9,610 $429,000
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $49,885 - $80,498	1,029 Added 20.65%	6,012 $303,000
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $250,644 - $390,866	4,983 New	4,983 $391,000
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $158,710 - $240,513	-2,950 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $226,873 - $575,394	-6,150 Reduced 67.58%	2,950 $247,000
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $41,842 - $70,261	-1,809 Reduced 16.58%	9,100 $326,000
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $174,653 - $314,397	10,909 New	10,909 $264,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $28.14 $78,236 - $119,004	-4,229 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $40,513 - $55,511	2,252 Added 113.91%	4,229 $98,000
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $27,440 - $42,999	1,977 New	1,977 $41,000

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account